Vimarsana
Biggest News Aggregation in the World

Page 3 - Ann Intern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ann Intern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ann Intern Today - Breaking & Trending Today

Switch to Efmoroctocog Alfa May Lower Bleeding Events in Hemophilia A - Vimarsana News

Switch to Efmoroctocog Alfa May Lower Bleeding Events in Hemophilia A

Patients in France with hemophilia A who switched their FVIII replacement treatment trended towards fewer bleeding events and articular non-bleeding events requiring hospitalization.

The Importance of Lung Cancer Screening in Individuals Exposed to the World Trade Center Disaster - Vimarsana News

The Importance of Lung Cancer Screening in Individuals Exposed to the World Trade Center Disaster

Investigators evaluated risk factor–based guidelines and risk model–based strategies for lung cancer screening in World Trade Center–exposed responders.

eGFR Based on Creatinine, Cystatin C May Offer Better CKD Threshold for Older Adults - Vimarsana News

eGFR Based on Creatinine, Cystatin C May Offer Better CKD Threshold for Older Adults

Low eGFRcr-cys was more strongly and uniformly associated with adverse outcomes compared to low eGFRcr in an older patient population, highlighting the benefit of including cystatin C in GFR estimation.

Analysis Explores Gene Therapy's Potential to Be Cost Effective in SCD - Vimarsana News

Analysis Explores Gene Therapy's Potential to Be Cost Effective in SCD

This new economic valuation of the societal and health care benefits of gene therapy to treat sickle cell disease (SCD) concludes the highly personalized treatment has potential to be cost effective if priced below $2 million.

Source: ajmc.com
CBT-I, Trazodone Ineffective at Improving Insomnia for Patients on Hemodialysis - Vimarsana News

CBT-I, Trazodone Ineffective at Improving Insomnia for Patients on Hemodialysis

Investigators observed no change in Insomnia Severity Index scores from baseline to weeks 7 and 25 with CBT-1, trazodone, or placebo, suggesting these insomnia treatment options are not effective for patients undergoing hemodialysis.